Notice of Knight Therapeutics' Third Quarter 2019 Results Conference Call
MONTREAL, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading Canadian specialty pharmaceutical company, will release its third quarter 2019 financial results on Tuesday, November 12, 2019 after market closing. …